<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:41:02Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6530078" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6530078</identifier>
        <datestamp>2019-06-07</datestamp>
        <setSpec>bmjgroup</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Ann Rheum Dis</journal-id>
              <journal-id journal-id-type="iso-abbrev">Ann. Rheum. Dis</journal-id>
              <journal-id journal-id-type="hwp">annrheumdis</journal-id>
              <journal-id journal-id-type="publisher-id">ard</journal-id>
              <journal-title-group>
                <journal-title>Annals of the Rheumatic Diseases</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0003-4967</issn>
              <issn pub-type="epub">1468-2060</issn>
              <publisher>
                <publisher-name>BMJ Publishing Group</publisher-name>
                <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6530078</article-id>
              <article-id pub-id-type="pmcid">PMC6530078</article-id>
              <article-id pub-id-type="pmc-uid">6530078</article-id>
              <article-id pub-id-type="pmid">30793700</article-id>
              <article-id pub-id-type="pmid">30793700</article-id>
              <article-id pub-id-type="publisher-id">annrheumdis-2018-214469</article-id>
              <article-id pub-id-type="doi">10.1136/annrheumdis-2018-214469</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Rheumatoid Arthritis</subject>
                </subj-group>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1506</subject>
                  <subject>2311</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT)</article-title>
              </title-group>
              <contrib-group>
                <contrib id="author-22407813" contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7851-2039</contrib-id>
                  <name>
                    <surname>Hewlett</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib id="author-37031465" contrib-type="author">
                  <name>
                    <surname>Almeida</surname>
                    <given-names>Celia</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib id="author-37031571" contrib-type="author">
                  <name>
                    <surname>Ambler</surname>
                    <given-names>Nicholas</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">2</xref>
                </contrib>
                <contrib id="author-65199040" contrib-type="author">
                  <name>
                    <surname>Blair</surname>
                    <given-names>Peter S</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">3</xref>
                </contrib>
                <contrib id="author-23814651" contrib-type="author">
                  <name>
                    <surname>Choy</surname>
                    <given-names>Ernest H</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">4</xref>
                </contrib>
                <contrib id="author-37030697" contrib-type="author">
                  <name>
                    <surname>Dures</surname>
                    <given-names>Emma</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib id="author-23178045" contrib-type="author">
                  <name>
                    <surname>Hammond</surname>
                    <given-names>Alison</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff5">5</xref>
                </contrib>
                <contrib id="author-65199091" contrib-type="author">
                  <name>
                    <surname>Hollingworth</surname>
                    <given-names>William</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">3</xref>
                </contrib>
                <contrib id="author-65199120" contrib-type="author">
                  <name>
                    <surname>Kadir</surname>
                    <given-names>Bryar</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">3</xref>
                </contrib>
                <contrib id="author-22408219" contrib-type="author">
                  <name>
                    <surname>Kirwan</surname>
                    <given-names>John Richard</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff6">6</xref>
                </contrib>
                <contrib id="author-65199136" contrib-type="author">
                  <name>
                    <surname>Plummer</surname>
                    <given-names>Zoe</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib id="author-65199164" contrib-type="author">
                  <name>
                    <surname>Rooke</surname>
                    <given-names>Clive</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff7">7</xref>
                </contrib>
                <contrib id="author-65199185" contrib-type="author">
                  <name>
                    <surname>Thorn</surname>
                    <given-names>Joanna</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">3</xref>
                </contrib>
                <contrib id="author-65199201" contrib-type="author">
                  <name>
                    <surname>Turner</surname>
                    <given-names>Nicholas</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff8">8</xref>
                </contrib>
                <contrib id="author-35928476" contrib-type="author">
                  <name>
                    <surname>Pollock</surname>
                    <given-names>Jon</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff9">9</xref>
                </contrib>
                <on-behalf-of>on behalf of the RAFT Study Group</on-behalf-of>
              </contrib-group>
              <contrib-group content-type="collaborators">
                <contrib contrib-type="collab">
                  <collab>RAFT Study Group
<contrib-group content-type="collaborators"><contrib contrib-type="collab"><name><surname>Creamer</surname><given-names>P</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Hughes</surname><given-names>R</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Knops</surname><given-names>B</given-names></name></contrib><contrib contrib-type="collab"><name><surname>Cheston</surname><given-names>R</given-names></name></contrib></contrib-group></collab>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution content-type="department">Department of Nursing and Midwifery</institution>, <institution>University of the West of England Bristol</institution>, <addr-line content-type="city">Bristol</addr-line>, <country>UK</country></aff>
              <aff id="aff2"><label>2</label><institution content-type="department">Pain Management Centre</institution>, <institution>Southmead Hospital</institution>, <addr-line content-type="city">Bristol</addr-line>, <country>UK</country></aff>
              <aff id="aff3"><label>3</label><institution content-type="department">Department of Population Health Sciences</institution>, <institution>University of Bristol</institution>, <addr-line content-type="city">Bristol</addr-line>, <country>UK</country></aff>
              <aff id="aff4"><label>4</label><institution content-type="department">Section of Rheumatology, Division of Infection and Immunity</institution>, <institution>Cardiff University</institution>, <addr-line content-type="city">Cardiff</addr-line>, <country>UK</country></aff>
              <aff id="aff5"><label>5</label><institution content-type="department">Centre for Health Sciences Research, School of Health Sciences</institution>, <institution>University of Salford</institution>, <addr-line content-type="city">Salford</addr-line>, <country>UK</country></aff>
              <aff id="aff6"><label>6</label><institution content-type="department">Department of Translational Health Sciences, Academic Rheumatology</institution>, <institution>University of Bristol</institution>, <addr-line content-type="city">Bristol</addr-line>, <country>UK</country></aff>
              <aff id="aff7"><label>7</label><institution content-type="department">Patient Research Partner, Academic Rheumatology</institution>, <institution>Bristol Royal Infirmary</institution>, <addr-line content-type="city">Bristol</addr-line>, <country>UK</country></aff>
              <aff id="aff8"><label>8</label><institution content-type="department">Bristol Randomised Trials Collaboration, Bristol Trials Centre</institution>, <institution>University of Bristol</institution>, <addr-line content-type="city">Bristol</addr-line>, <country>UK</country></aff>
              <aff id="aff9"><label>9</label><institution content-type="department">Department of Health and Social Sciences</institution>, <institution>University of the West of England Bristol</institution>, <addr-line content-type="city">Bristol</addr-line>, <country>UK</country></aff>
              <author-notes>
                <corresp><label>Correspondence to</label> Professor Sarah Hewlett, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol BS2 8HW, UK; <email>sarah.hewlett@uwe.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <month>4</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>6</day>
                <month>2</month>
                <year>2019</year>
              </pub-date>
              <volume>78</volume>
              <issue>4</issue>
              <fpage>465</fpage>
              <lpage>472</lpage>
              <history>
                <date date-type="received">
                  <day>20</day>
                  <month>9</month>
                  <year>2018</year>
                </date>
                <date date-type="rev-recd">
                  <day>08</day>
                  <month>1</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>11</day>
                  <month>1</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license license-type="open-access">
                  <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="annrheumdis-2018-214469.pdf"/>
              <abstract>
                <sec>
                  <title>Objectives</title>
                  <p>To see if a group course delivered by rheumatology teams using cognitive-behavioural approaches, plus usual care, reduced RA fatigue impact more than usual care alone.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>Multicentre, 2-year randomised controlled trial in RA adults (fatigue severity<underline>&gt;</underline>6/10, no recent major medication changes). RAFT (Reducing Arthritis Fatigue: clinical Teams using CB approaches) comprises seven sessions, codelivered by pairs of trained rheumatology occupational therapists/nurses. Usual care was Arthritis Research UK fatigue booklet. Primary 26-week outcome fatigue impact (Bristol RA Fatigue Effect Numerical Rating Scale, BRAF-NRS 0–10). Intention-to-treat regression analysis adjusted for baseline scores and centre.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>308/333 randomised patients completed 26 week data (156/175 RAFT, 152/158 Control). Mean baseline variables were similar. At 26 weeks, the adjusted difference between arms for fatigue impact change favoured RAFT (BRAF-NRS Effect −0.59, 95% CI –1.11 to -0.06), BRAF Multidimensional Questionnaire (MDQ) Total −3.42 (95% CI –6.44 to -0.39), Living with Fatigue −1.19 (95% CI –2.17 to -0.21), Emotional Fatigue −0.91 (95% CI –1.58 to -0.23); RA Self-Efficacy (RASE, +3.05, 95% CI 0.43 to 5.66) (14 secondary outcomes unchanged). Effects persisted at 2 years: BRAF-NRS Effect −0.49 (95% CI −0.83 to -0.14), BRAF MDQ Total −2.98 (95% CI −5.39 to -0.57), Living with Fatigue −0.93 (95% CI −1.75 to -0.10), Emotional Fatigue −0.90 (95% CI −1.44, to -0.37); BRAF-NRS Coping +0.42 (95% CI 0.08 to 0.77) (relevance of fatigue impact improvement uncertain). RAFT satisfaction: 89% scored <underline>&gt;</underline> 8/10 vs 54% controls rating usual care booklet (p&lt;0.0001).</p>
                </sec>
                <sec>
                  <title>Conclusion</title>
                  <p>Multiple RA fatigue impacts can be improved for 2 years by rheumatology teams delivering a group programme using cognitive behavioural approaches.</p>
                </sec>
                <sec>
                  <title>Trial registration number</title>
                  <p><ext-link ext-link-type="uri" xlink:href="ISRCTN52709998">ISRCTN52709998</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>rheumatoid arthritis</kwd>
                <kwd>fatigue</kwd>
                <kwd>cognitive behavioural therapy</kwd>
                <kwd>randomised controlled trial</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>special-feature</meta-name>
                  <meta-value>unlocked</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text id="BX1" position="float" orientation="portrait">
              <caption>
                <title>Key messages</title>
              </caption>
              <sec>
                <title>What is already known about this subject?</title>
                <list list-type="bullet">
                  <list-item>
                    <p>Fatigue in rheumatoid arthritis is common and cognitive behavioural therapy can help, but few rheumatology units have clinical psychologists to deliver it.</p>
                  </list-item>
                </list>
              </sec>
              <sec>
                <title>What does this study add?</title>
                <list list-type="bullet">
                  <list-item>
                    <p>This study demonstrates that rheumatology nurses and occupational therapists using cognitive behavioural approaches can reduce fatigue impact with both short-term and long-term effects.</p>
                  </list-item>
                </list>
              </sec>
              <sec>
                <title>How might this impact on clinical practice or future developments?</title>
                <list list-type="bullet">
                  <list-item>
                    <p>All seven clinical teams were able to deliver this intervention, suggesting future clinical implementation is feasible.</p>
                  </list-item>
                </list>
              </sec>
            </boxed-text>
            <sec id="s1">
              <title>Background</title>
              <p>Fatigue is a significant problem for people with rheumatoid arthritis,<xref rid="R1" ref-type="bibr">1</xref> incorporating physical exhaustion and cognitive impairment, with impacts on lifestyle, roles, relationships and emotions.<xref rid="R2" ref-type="bibr">2 3</xref> RA fatigue is persistent,<xref rid="R4" ref-type="bibr">4</xref> patients feel unsupported by rheumatology teams and rheumatology nurses want help regarding fatigue management.<xref rid="R2" ref-type="bibr">2 5</xref> The RA fatigue causal pathway remains unclear.<xref rid="R6" ref-type="bibr">6</xref> Multiple factors may form different combinations and weightings for each patient at each episode. A conceptual framework proposes three main components: inflammation (directly or through pain, sleep disruption, disability), personal factors (eg, work, comorbidities) and cognitive behavioural elements (under/over activity, driven by thoughts/feelings).<xref rid="R7" ref-type="bibr">7</xref> Meta-analysis of randomised controlled trials (RCTs) reporting RA fatigue shows small-moderate effects from biological disease modifying anti-rheumatic drugs and physical exercise, although fatigue was rarely the primary outcome.<xref rid="R8" ref-type="bibr">8 9</xref></p>
              <p>Meta-analysis of psycho-educational interventions reporting RA fatigue also shows small-moderate benefit.<xref rid="R10" ref-type="bibr">10</xref> However, only two specifically addressed RA fatigue.<xref rid="R10" ref-type="bibr">10 11</xref> One intervention targeted distress, comprising 1–1 cognitive behavioural therapy (CBT), with an optional fatigue module.<xref rid="R10" ref-type="bibr">10</xref> The second intervention aimed to reduced fatigue impact, using group CBT.<xref rid="R11" ref-type="bibr">11</xref> Both improved fatigue/fatigue impact but were delivered by clinical psychologists, meaning they are hard to implement in the current NHS as few rheumatology teams include clinical psychologists.<xref rid="R12" ref-type="bibr">12</xref> The aim of this trial was to see if usual care plus a group course delivered by rheumatology teams using cognitive-behavioural approaches (CBA) reduced RA fatigue impact more than usual care alone.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <p>The detailed methods have been published<xref rid="R13" ref-type="bibr">13</xref> and a summary is provided here.</p>
              <sec id="s2-1">
                <title>Trial design</title>
                <p>UK, 7-centre randomised controlled trial of group CBA for fatigue self-management plus usual care (1–1 fatigue information) versus usual care alone.</p>
              </sec>
              <sec id="s2-2">
                <title>Participants</title>
                <p>Eligible patients were aged <underline>&gt;</underline>18 years with confirmed RA<xref rid="R14" ref-type="bibr">14</xref> and fatigue severity <underline>&gt;</underline>6/10 on a Numerical Rating Scale (NRS),<xref rid="R15" ref-type="bibr">15</xref> which they considered recurrent or persistent. Exclusion criteria were recent changes to glucocorticoids (6 weeks) or major RA medication (16 weeks) or insufficient English to participate in group discussions. Patients were approached in clinic or by mailshots to departmental databases. Ethics approval was obtained (East of England Norfolk 13/EE/0310), the trial registered (ISRCTN52709998) and patients gave written informed consent.</p>
              </sec>
              <sec id="s2-3">
                <title>Interventions</title>
                <p>RAFT is the group course for RA fatigue using CBT approaches previously facilitated by a clinical psychologist.<xref rid="R11" ref-type="bibr">11</xref> RAFT comprises seven sessions (weeks 1–6 for 2 hours, consolidation week 14 for 1 hour), addressing behaviours likely to be related to fatigue and their underpinning thoughts and feelings (see <xref ref-type="supplementary-material" rid="SP1">online supplementary data</xref>), as previously published.<xref rid="R13" ref-type="bibr">13</xref> Tutors use exploratory questioning, goal-setting and peer-support to enhance self-efficacy (belief that you can succeed with an activity), prompting changes in self-management.<xref rid="R16" ref-type="bibr">16 17</xref> RAFT was manualised for codelivery by pairs of rheumatology nurses/occupational therapists, who trained together over 4 days and delivered an observed course locally before the RCT.<xref rid="R13" ref-type="bibr">13</xref></p>
                <supplementary-material content-type="local-data" id="SP1">
                  <object-id pub-id-type="doi">10.1136/annrheumdis-2018-214469.supp1</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS1" xlink:href="annrheumdis-2018-214469supp001.docx" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" mimetype="application" content-type="local-data"/>
                  </p>
                </supplementary-material>
                <p>Usual care was the Arthritis Research UK fatigue self-management booklet, based on the original RAFT intervention,<xref rid="R18" ref-type="bibr">18</xref> provided to and discussed with each patient for approximately 5 min by the research nurse at the baseline visit (ie, pre-randomisation).</p>
              </sec>
              <sec id="s2-4">
                <title>Outcomes</title>
                <p>The primary outcome was fatigue impact at 26 weeks, collected by the central trial team by telephone using the Bristol RA Fatigue Numerical Rating Scale (BRAF-NRS Effect).<xref rid="R15" ref-type="bibr">15</xref> Other fatigue elements were severity, coping (BRAF-NRSs) and overall impact (BRAF Multidimensional Questionnaire, BRAF-MDQ).<xref rid="R15" ref-type="bibr">15</xref> Clinical status comprised pain (NRS), disability (Modified Health Assessment Questionnaire, MHAQ),<xref rid="R19" ref-type="bibr">19</xref> sleep (item from Pittsburgh Sleep Quality Index),<xref rid="R20" ref-type="bibr">20</xref> disease activity (DAS28<xref rid="R21" ref-type="bibr">21</xref> at weeks 0 and 26, replaced at other time-points by self-report (sPDAS2),<xref rid="R22" ref-type="bibr">22 23</xref> mood (Hospital Anxiety and Depression scale, HADS),<xref rid="R24" ref-type="bibr">24</xref> quality of life (global question, Arthritis Impact Measurement Scale, AIMS)<xref rid="R25" ref-type="bibr">25</xref> and leisure activities (discretionary activity subscale, Valued Life Activities, VLA).<xref rid="R26" ref-type="bibr">26</xref> Self-efficacy and helplessness underpinning processes were assessed (RA Self-Efficacy scale (RASE), Arthritis Helplessness Index (AHI)).<xref rid="R27" ref-type="bibr">27 28</xref> Outcomes were measured at weeks 0, 6, 26, 52, 78 and 104. At weeks 10 and 18, fatigue was measured for exploratory analysis of the week 14 consolidation session. Satisfaction with RAFT/booklet (26 weeks) and social contact (weeks 52, 104) comprised unvalidated questions. Economic and qualitative evaluations will be reported elsewhere.</p>
              </sec>
              <sec id="s2-5">
                <title>Sample size</title>
                <p>With 90% power and a two-sided significance of 0.05, 73 patients/arm would detect 1.46 units difference in fatigue impact (effect size 0.54), equal to 75% of the 1.95 units difference achieved by a CBT therapist (SD 2.7, effect size 0.77).<xref rid="R11" ref-type="bibr">11</xref> Potential for clustering effects from groups/tutors increased this to 75/arm and allowing for 2 year attrition (50%) we aimed to recruit 150/arm.<xref rid="R29" ref-type="bibr">29</xref></p>
              </sec>
              <sec id="s2-6">
                <title>Randomisation</title>
                <p>Seven centres each recruited four trial cohorts over 2 years. Once a centre recruited 10–16 participants (cohort), informed consent and baseline assessments were conducted. Computer-generated randomisation for that cohort was performed by the Bristol Randomised Trials Collaboration; thus, randomisation was stratified by centre, and within centres by cohort (1-4). Allocation was 1:1 with the RAFT arm receiving the additional patient if numbers were uneven. Patients randomised to RAFT but unable to attend their course were offered subsequent courses. All patients eligible at screening were accepted, even if they had become ineligible by baseline (medication/fatigue changes) while awaiting full cohort recruitment, mirroring the pragmatic nature of chronic illness interventions.</p>
              </sec>
              <sec id="s2-7">
                <title>Blinding</title>
                <p>RAFT group courses meant blinding of patients and clinicians was impossible, but data were analysed blind to arm allocation.</p>
              </sec>
              <sec id="s2-8">
                <title>Statistical methods</title>
                <p>Analysis followed a predefined plan, used STATA V.14.1.1, reported using CONSORT guidelines.<xref rid="R30" ref-type="bibr">30</xref> Analyses were conducted on an intention-to-treat (ITT) basis without imputation of missing data, adjusting for baseline value and centre. Primary effectiveness analysis used linear regression to estimate an adjusted mean difference comparing fatigue impact at 26 weeks (primary outcome) between groups as randomised. Analysis was repeated including 20 sets of imputed missing primary outcome data. The multiple imputation model included all variables that were part of the ITT primary analysis, variables potentially related to fatigue impact (fatigue severity, pain, self-rated and nurse-rated disease activity) and baseline variables that were associated with missingness of the primary outcome. Secondary analysis compared groups across 26, 52, 78 and 104 weeks using a mixed effects model (treatment arm baseline measure of the outcome, centre and timepoint as fixed effects and participant as a random effect to account for the repeated measures nature of the data). Further secondary analyses of the primary outcome included: restricting the analysis to baseline-eligible participants (ie, fatigue severity <underline>&gt;</underline>6/10); a Complier Average Causal Effect (CACE) analysis to investigate the efficacy of the intervention (based on treatment compliance status) for comparison with the ITT estimate of the offer of the intervention<xref rid="R31" ref-type="bibr">31</xref> and investigation of potential clustering by centre and group. Secondary outcomes at 26 weeks were examined using linear regression for continuous outcomes and logistic regression for binary outcomes (adjusted for baseline measure of the outcome and centre) and over 26, 52, 78 and 104 weeks using the mixed effects models above. Potential predictors of fatigue impact change were modelled using stepwise deletion. Exploratory analyses assessed the effects of a potential tutor learning curve, the week 14 consolidation session and individual self-efficacy (RASE) questions at 26 weeks (t-test).</p>
              </sec>
              <sec id="s2-9">
                <title>Patient involvement</title>
                <p>Patient partners (Rooke, Robinson) brought experiential knowledge of RA fatigue and received the original CBT intervention.<xref rid="R11" ref-type="bibr">11</xref> They advised on outcomes, questionnaires, handouts, recruitment and supported tutor training; Rooke provided advice on the tutor manual, attended project meetings and interpreted results.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s3">
              <title>Results</title>
              <p>Four consecutive cohorts of 9–16 patients were randomised in each of 7 centres over 2 years (n=333) (<xref ref-type="fig" rid="F1">figure 1</xref>), with similar numbers across centres (see <xref ref-type="supplementary-material" rid="SP1">online supplementary data</xref>). Six of 158 patients randomised to usual care alone withdrew before week 26. While 6 of 175 patients randomised to RAFT attended a later course than planned (with fresh baseline data), 14 patients could not meet any local course dates and did not receive RAFT. Of the 161 patients who received RAFT, 4 withdrew for personal/health reasons (having attended 1–3 of the 7 sessions) and 1 before week 10. Therefore 156/175 RAFT patients (89.9%) and 152/158 control patients (96.0%) provided primary week 26 outcome data; 153/175 RAFT and 147/158 control patients provided week 104 data (87.4%, 93.0%).</p>
              <fig id="F1" orientation="portrait" position="float">
                <label>Figure 1</label>
                <caption>
                  <p>Participant flowchart. CBT, cognitive behavioural therapy.</p>
                </caption>
                <graphic xlink:href="annrheumdis-2018-214469f01"/>
              </fig>
              <sec id="s3-1">
                <title>RAFT delivery</title>
                <p>All 7 rheumatology centres provided at least two clinicians and of 15 trained, 14 went on to deliver RAFT: 4 nurse/occupational therapist pairs, 1 occupational therapist pair and 2 nurse pairs. Tutors had been qualified for a mean 18 years (6–30), with 5.3 years rheumatology experience (0–17); 10 had experience of group work, of whom 4 reported knowledge of goal-setting or CBT. All hospitals delivered four RAFT courses. Tutor pairs remained unchanged, apart from one centre where tutor absence was covered by the remaining tutor codelivering one course with a trainer and one with a colleague who had previously observed. Seven of the 196 RAFT sessions (28 courses of 7 sessions) were delivered by a single tutor due to absence (3.6%). Independent monitoring of two sessions of every course confirmed tutor fidelity to RAFT content, delivery and CB principles.</p>
              </sec>
              <sec id="s3-2">
                <title>RAFT attendance</title>
                <p>At randomisation, RAFT groups averaged six patients (5-8). Patients attended a mean 5.85 of their 7 RAFT sessions (SD 1.63), with 136 (87.2%) attending 5–7. All 156 RAFT patients attended their Session 1 (definition of having received RAFT), and each of the individual Sessions 2–7 was attended by <underline>&gt;</underline>75% randomised patients. No related adverse events reported.</p>
              </sec>
              <sec id="s3-3">
                <title>Baseline data</title>
                <p>Total 308/333 randomised patients completed primary 26 week outcome data. Baseline characteristics were similar between arms, being primarily female (RAFT 125/156, 80.1%, control 121/152, 79.6%), &gt;60 years old (RAFT median 63.7, IQR 54.2, 69.9; control 61.8, IQR 54.4, 69.6) and a median 10 year disease duration (RAFT IQR 5, 19; control 3, 20). Baseline clinical data were similar between arms (<xref rid="T1" ref-type="table">table 1</xref>) with high fatigue impact (mean BRAF-NRS Effect &gt;7/10) that was slightly higher than fatigue severity, low perceived ability to cope with fatigue, relatively high baseline disease activity (mean DAS28&gt;4.2), moderate pain, low disability, moderate self-efficacy and helplessness. The 25 patients who withdrew had similar characteristics (see <xref ref-type="supplementary-material" rid="SP1">online supplementary data</xref>). During the trial, normal clinical management meant patients had changes to major RA medications but this was not different between arms (see <xref ref-type="supplementary-material" rid="SP1">online supplementary data</xref>).</p>
                <table-wrap id="T1" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline clinical data</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="2" colspan="1"/>
                        <td align="left" valign="bottom" colspan="2" rowspan="1">Control (n=158)</td>
                        <td align="left" valign="bottom" colspan="2" rowspan="1">RAFT (n=175)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n (%)*</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n (%)*</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Mean (SD)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Fatigue</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-NRS Effect (0–10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (96.2)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.23 (1.6)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">156 (89.1)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.10 (1.7)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-NRS Severity (0–10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.85 (1.57)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.89 (1.57)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-NRS Coping (0–10)†</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.84 (2.09)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.16 (2.08)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ impact overall (0–70)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">40.39 (12.99)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">40.42 (12.70)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Physical (0–22)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">16.19 (3.21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">16.12 (3.39)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Emotional (0–12)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.71 (3.31)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.55 (3.18)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Cognitive (0–15)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.58 (4.04)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.54 (4.00)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Living with (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">9.90 (5.18)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">10.21 (5.05)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Pain NRS (0–10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.57 (2.10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.70 (2.12)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Disability MHAQ (0–3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.76 (0.51)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.75 (0.53)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Quality of life AIMS VAS (0–100)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">141 (89.2)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">49.89 (20.44)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">49.16 (22.27)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Disease activity</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Assessed—DAS28 (0.96+)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">145 (91.8)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.23 (1.11)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">147 (84.0)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.22 (1.30)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Self-report—sPDAS2 (2.4–7.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.36 (0.99)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.44 (1.06)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Anxiety HADS (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">8.01 (4.45)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.29 (4.08)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Depression HADS (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.79 (3.94)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.18 (3.59)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Valued life activities (0–3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1.08 (0.60)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1.16 (0.61)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Helplessness AHI (5-30)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">18.98 (4.74)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">19.03 (4.67)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Self-efficacy RASE (28-140)††</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">104.38 (11.34)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">102.49 (11.51)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Sleep quality</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">149 (85.1)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Very good‡</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5 (3.5%)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">9 (6.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Fairly good‡</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">58 (40.9%)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">48 (32.2%)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Fairly bad‡</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">51 (35.9%)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">56 (37.6%)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Very bad‡</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">28 (19.7%)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">36 (24.2%)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T1_FN1">
                      <p>*Percentage of total randomised (Control 158, RAFT 175).</p>
                    </fn>
                    <fn id="T1_FN2">
                      <p>†Higher score=better outcome.</p>
                    </fn>
                    <fn id="T1_FN3">
                      <p>‡Percentage of questionnaires returned.</p>
                    </fn>
                    <fn id="T1_FN4">
                      <p>AHI, Arthritis Helplessness Index; AIMS, Arthritis Impact Measurement Scale; BRAF-MDQ, Bristol RA Fatigue Multidimensional Questionnaire; BRAF-NRS, Bristol RA Fatigue Numerical Rating Scale; HADS, Hospital Anxiety and Depression Scale; MHAQ, Modified Health Assessment Questionnaire; RASE, RA Self-Efficacy.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s3-4">
                <title>Primary outcome</title>
                <p>At week 26, mean BRAF-NRS impact was reduced by 1.36 units (p&lt;0.001) in RAFT compared with 0.88 in controls (p&lt;0.004).<xref rid="R32" ref-type="bibr">32 33</xref> Regression analysis showed a difference between changes in fatigue impact NRS of −0.59 in favour of RAFT (p=0.03, <xref rid="T2" ref-type="table">table 2</xref>), giving a standardised effect size of 0.36 (adjusted difference in mean/pooled baseline SD).</p>
                <table-wrap id="T2" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Primary outcome of fatigue impact at 26 weeks</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="2" colspan="1"/>
                        <td align="left" valign="bottom" colspan="3" rowspan="1">Control</td>
                        <td align="left" valign="bottom" colspan="3" rowspan="1">RAFT</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">Adjusted* mean difference<break/>(95% CI)</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">P value</td>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n (%)†</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Week 0<break/>Mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Week 26<break/>Mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n (%)†</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Week 0<break/>Mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Week 26<break/>Mean (SD)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">BRAF-NRS effect</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (96.2)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.23 (1.6)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.36 (2.42)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">156 (89.1)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.10 (1.7)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.74 (2.41)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">−0.59 (−1.11 to -0.06)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T2_FN1">
                      <p>*Linear regression adjusted for baseline BRAF-NRS impact and centre.</p>
                    </fn>
                    <fn id="T2_FN2">
                      <p>†Percentage of total randomised (Control 158, RAFT 175).</p>
                    </fn>
                    <fn id="T2_FN3">
                      <p>BRAF-NRS, Bristol RA Fatigue Numerical Rating Scale.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The primary analysis was repeated excluding patients who had fallen below the BRAF-NRS Severity&gt;6/10 eligibility criterion between screening and baseline (23/156 RAFT, 23/152 control). For baseline-eligible patients, a larger effect was seen in favour of RAFT, with an adjusted mean difference between arms for fatigue impact of −0.82 (95% CI −1.40 to -0.24, p=0.01).</p>
                <p>Analysis on 20 sets of imputed data gave almost identical results (adjusted mean difference between arms for fatigue impact −0.58), therefore no further imputation was used. CACE analysis supported the finding of a larger effect from RAFT in those who ‘complied’ with the intervention compared with the ITT estimate of the ‘offer’ of the intervention (CACE treatment effect estimate −0.69). However, CACE methods could be deemed inappropriate as 14 patients randomised to but not attending RAFT had no follow-up data (see <xref ref-type="supplementary-material" rid="SP1">online supplementary data</xref>). No evidence of clustering was demonstrated: log-likelihood of linear mixed model −696.44 vs log-likelihood of model not adjusting for clustering −696.48 (p=0.96).</p>
              </sec>
              <sec id="s3-5">
                <title>Primary outcome over two years</title>
                <p>Difference between the arms for fatigue impact was maintained over 2 years (<xref ref-type="fig" rid="F2">figure 2</xref>). RAFT patients had a BRAF-NRS Impact score that was on average better than controls over 2 years with an adjusted mean difference of −0.49 (95% CI −0.83 to -0.14, p=0.01) (see <xref ref-type="supplementary-material" rid="SP1">online supplementary data</xref>). The mixed effects model conducted on baseline-eligible patients again showed a slightly larger treatment effect with an average adjusted mean difference over 2 years of −0.58 (95% CI −0.95 to -0.22, p=0.002).</p>
                <fig id="F2" orientation="portrait" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>BRAF-NRS Impact scores (0–10) over weeks 0–104 by trial arm. BRAF-NRS, Bristol RA Fatigue Numerical Rating Scale.</p>
                  </caption>
                  <graphic xlink:href="annrheumdis-2018-214469f02"/>
                </fig>
              </sec>
              <sec id="s3-6">
                <title>Secondary outcomes</title>
                <p>There was a difference between arms at 26 weeks in favour of RAFT for overall fatigue impact, emotional fatigue, living with fatigue (BRAF-MDQ Overall and subscales) and self-efficacy (RASE) (<xref rid="T3" ref-type="table">table 3</xref>). Findings were similar over 2 years, when better outcomes for fatigue coping (BRAF-NRS Coping) also emerged for RAFT whereas self-efficacy was no longer significant (<xref rid="T4" ref-type="table">table 4</xref>). There was no difference between arms for the other 13 secondary outcomes, including fatigue severity (<xref rid="T3 T4" ref-type="table">tables 3 and 4</xref>).</p>
                <table-wrap id="T3" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Adjusted mean difference between arms in secondary outcomes at 26 weeks</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="2" colspan="1"/>
                        <td align="left" valign="bottom" colspan="2" rowspan="1">Control</td>
                        <td align="left" valign="bottom" colspan="2" rowspan="1">RAFT</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">Adjusted mean difference*<break/>(95% CI)</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">P value</td>
                        <td align="left" valign="bottom" rowspan="2" colspan="1">Effect size</td>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n (%)†</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Mean (SD)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">n (%)†</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Mean (SD)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Fatigue</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-NRS Severity (0–10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.13 (2.30)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.91 (2.22)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.24 (−0.75 to 0.27)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.35</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-NRS Coping (0-10)‡</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.32 (2.42)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.25 (2.33)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.15 (−0.69 to 0.39)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.58</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Impact Overall (0–70)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">34.74 (16.41)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">31.51 (16.02)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−3.42 (−6.44 to -0.39)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.27</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Physical (0–22)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">14.40 (5.23)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">13.72 (4.91)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.68 (−1.78 to 0.42)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.23</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Emotional (0–12)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.36 (3.79)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.37 (3.51)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.91 (−1.58 to -0.23)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.28</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Cognitive (0–15)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.55 (4.16)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.89 (4.35)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.66 (−1.45 to 0.13)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.10</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Living with (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">8.43 (5.68)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.53 (5.43)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−1.19 (−2.17 to -0.21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.23</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Pain NRS (0–10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.24 (2.41)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">5.47 (2.32)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">0.16 (−0.33 to 0.65)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.51</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Disability MHAQ (0–3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.70 (0.51)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.71 (0.54)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">0.02 (−0.06 to 0.10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.67</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Quality of Life AIMS VAS (0–100)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">141 (89.2)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">47.70 (23.04)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">47.22 (23.46)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.33 (−5.13 to 4.65)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.90</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Disease Activity:</td>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Assessed—DAS28 (0.96+)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">145 (91.8)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.10 (1.31)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">147 (84.0)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.13 (1.38)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">0.02 (−0.21 to 0.24)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.88</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Self-report—sPDAS2 (2.4–7.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.33 (1.04)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">4.44 (1.13)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">0.05 (−0.16 to 0.26)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.63</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Anxiety HADS (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">7.56 (4.48)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.65 (4.36)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.33 (−0.95 to 0.29)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.30</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Depression HADS (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.42 (4.06)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">6.22 (3.76)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.50 (−1.14 to 0.14)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.13</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Valued Life Activities (0–3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1.07 (0.62)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1.09 (0.67)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.05 (−0.15 to 0.05)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.34</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Helplessness AHI (5-30)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">17.47 (5.46)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">152 (86.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">16.92 (5.06)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1">−0.61 (−1.65 to 0.43)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.25</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Self-efficacy RASE (28-140)‡</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">142 (89.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">104.67 (13.31)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">151 (86.3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">106.26 (14.78)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">3.05 (0.43 to 5.66)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.27</td>
                      </tr>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Sleep quality:</td>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Very good§</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">9 (6.3%)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">17 (11.4%)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.75 (0.47 to 1.17)¶</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.21</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Fairly good§</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">65 (45.8%)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">64 (43.0%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Fairly bad§</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">51 (35.9%)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">51 (34.2%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Very bad§</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">17 (12.0%)</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">17 (11.4%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T3_FN1">
                      <p>*Linear regression adjusted for baseline measure of outcome and centre.</p>
                    </fn>
                    <fn id="T3_FN2">
                      <p>†Percentage of total randomised (Control 158, RAFT 175).</p>
                    </fn>
                    <fn id="T3_FN3">
                      <p>‡Higher score=better outcome.</p>
                    </fn>
                    <fn id="T3_FN4">
                      <p>§Number of patients (% questionnaires returned).</p>
                    </fn>
                    <fn id="T3_FN5">
                      <p>¶OR from ordinal logistic regression.</p>
                    </fn>
                    <fn id="T3_FN6">
                      <p>AHI, Arthritis Helplessness Index; AIMS, Arthritis Impact Measurement Scale; BRAF-MDQ, Bristol RA Fatigue Multidimensional Questionnaire; BRAF-NRS, Bristol RA Fatigue Numerical Rating Scale; HADS, Hospital Anxiety and Depression Scale; MHAQ, Modified Health Assessment Questionnaire; RASE, RA Self-Efficacy.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap id="T4" orientation="portrait" position="float">
                  <label>Table 4</label>
                  <caption>
                    <p>Mixed effects models examining effect of raft on secondary outcomes over 2 years</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Adjusted mean difference*</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">95% CI</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">P value</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Fatigue</td>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                        <td valign="top" align="char" char="." rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-NRS Severity (0–10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.17</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.54 to 0.20</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.38</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-NRS Coping (0–10)†</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.42</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.08 to 0.77</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Impact Overall (0–70)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−2.98</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−5.39 to -0.57</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Physical (0–22)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.64</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−1.45 to 0.17</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.12</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Emotional (0–12)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.90</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−1.44 to -0.37</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.001</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Cognitive (0–15)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.53</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−1.14 to 0.08</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.09</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> BRAF-MDQ Living with (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.93</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">-1.75 to -0.10</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Pain NRS (0–10)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.38 to 0.40</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.94</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Disability MHAQ (0–3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.01</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.07 to 0.08</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.86</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Quality of Life AIMS VAS (0–100)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.02</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−3.91 to 3.86</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.99</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Disease activity sPDAS2 (2.4–7.9)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.03</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.15 to 0.20</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.77</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Anxiety HADS (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.40</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.96 to 0.15</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.16</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Depression HADS (0–21)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.49</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−1.06 to 0.08</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.09</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Valued Life Activities (0–3)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.06</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.14 to 0.03</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.22</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Helplessness AHI (5-30)</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.27</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−1.12 to 0.58</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.54</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Self-efficacy RASE (28-140)†</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">1.31</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">−0.80 to 3.42</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.23</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Sleep Quality</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.74‡</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.44 to 1.27</td>
                        <td align="char" char="." valign="top" rowspan="1" colspan="1">0.28</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T4_FN1">
                      <p>*Adjusted for baseline measure of outcome and centre.</p>
                    </fn>
                    <fn id="T4_FN2">
                      <p>†Higher score=better outcome (for all other scales lower score=better outcome).</p>
                    </fn>
                    <fn id="T4_FN3">
                      <p>‡OR from ordinal logistic regression.</p>
                    </fn>
                    <fn id="T4_FN4">
                      <p>AHI, Arthritis Helplessness Index; AIMS, Arthritis Impact Measurement Scale; BRAF-MDQ, Bristol RA Fatigue Multidimensional Questionnaire; BRAF-NRS, Bristol RA Fatigue Numerical Rating Scale; HADS, Hospital Anxiety and Depression Scale; MHAQ, Modified Health Assessment Questionnaire; RASE, RA Self-Efficacy.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s3-7">
                <title>Patient satisfaction</title>
                <p>At 26 weeks, 89% of RAFT patients (133/150) rated course satisfaction <underline>&gt;</underline>8/10 compared with 54% (75/139) controls rating booklet satisfaction (p&lt;0.0001). Additionally, 96% of RAFT patients (144/150) were very likely to recommend it to others (scoring <underline>&gt;</underline>8/10) compared with 68% (95/139) controls recommending the booklet (p&lt;0.001). At 52 weeks, 20% of RAFT patients (n=35) had made further contact with their RAFT group, and 9% (16) at 104 weeks.</p>
              </sec>
              <sec id="s3-8">
                <title>Potential predictors of fatigue impact change</title>
                <p>The final linear regression model suggested worse outcome at 26 weeks was predicted by being female (0.75 unit increase in BRAF-NRS Effect, 95% CI 0.08 to 1.41, p=0.03) and higher baseline disease activity (1 unit increase in baseline DAS28 associated with 0.25 unit increase in BRAF-NRS Effect, 95% CI 0.02 to 0.49, p=0.04).</p>
                <p><italic>Exploratory analyses</italic> (see <xref ref-type="supplementary-material" rid="SP1">online supplementary data</xref>): The difference between arms in mean fatigue impact change was smallest in cohort 1 (−0.37 BRAF-NRS Effect) and greatest in cohort 4 (−0.82), suggesting possible tutor learning over time (the study was not powered to test this). The adjusted mean differences between arms for fatigue impact, coping with fatigue and emotional fatigue were greater at week 18 than week 10, suggesting benefit from the week 14 consolidation session, but could reflect random variation over time. RASE addresses self-efficacy for RA self-management, and six RASE items demonstrated a difference between arms for change in favour of RAFT at week 26: relaxation, pacing, accepting fatigue, asking for help, using relaxation tapes and avoiding things that cause pain.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>RAFT, a seven-session group CBA course for RA fatigue self-management delivered by rheumatology nurses and occupational therapists, reduced fatigue impact beyond usual care both at 6 months and 2 years. RAFT had high patient attendance and satisfaction. Improvements were also seen in emotional fatigue, living with fatigue, coping with fatigue and self-efficacy.</p>
              <p>Improvements in fatigue impact demonstrated in usual care alone were not seen in the previous RCT, where the control was one general self-management group session of didactic information.<xref rid="R11" ref-type="bibr">11</xref> The usual care fatigue booklet<xref rid="R18" ref-type="bibr">18</xref> in this RCT was written by the team following the original RCT.<xref rid="R12" ref-type="bibr">12</xref> A qualitative study suggested that patients felt the booklet made them feel more responsible for taking actions to manage their fatigue.<xref rid="R34" ref-type="bibr">34</xref> The brief booklet discussion with the nurse in this RCT may have had a greater effect than a patient picking up a booklet in clinic.</p>
              <p>The amount of fatigue impact change that might be clinically important for people with RA is unknown. The minimal clinically important difference (MCID) for RA fatigue severity scales averages 10%,<xref rid="R35" ref-type="bibr">35–37</xref> while multiple sclerosis fatigue impact MCID is 15%.<xref rid="R38" ref-type="bibr">38 39</xref> RAFTs demonstrated 19% change in fatigue impact and usual care 12% (–1.36, –0.88 units) are thus probably clinically meaningful.</p>
              <p>There was no treatment difference between arms for fatigue severity. Longitudinal studies demonstrate RA fatigue severity is largely stable with most having a persistent moderately high/high trajectory.<xref rid="R5" ref-type="bibr">5 40</xref> Symptom severity differs from impact: patients can report low impact from severe symptoms and vice versa.<xref rid="R41" ref-type="bibr">41 42</xref> Impact may be the product of interactions between symptom severity, personal importance and perceived coping.<xref rid="R43" ref-type="bibr">43</xref> The 2 year treatment difference in favour of RAFT for coping with fatigue might reflect reduced personal importance of fatigue, thus improving fatigue impact even with persistent fatigue severity. RAFT participants may have made a shift in how they view and manage fatigue, finding ways to reduce its impact.<xref rid="R44" ref-type="bibr">44</xref></p>
              <p>The 2-year effects of RAFT on fatigue coping suggest that patients’ newly acquired fatigue self-management skills became embedded. Core self-management skills taught in CB approaches may have translated into improved coping. Overall self-efficacy favoured RAFT at 26 weeks with changes in 6/28 RASE items of key fatigue self-management issues addressed in RAFT. Self-efficacy was no longer significant at 2 years, possibly reflecting the dominance of the 22 general RA self-management items in the RASE score over time since RAFT, compared with the focused fatigue coping NRS (ie, a measurement issue).</p>
              <sec id="s4-1">
                <title>Strengths and limitations</title>
                <p>The study’s external validity was strengthened by involving 7 hospitals, 14 tutors, broad entry criteria and strong patient and public involvement. The pragmatic trial design accommodated features of real clinical practice: natural variations in medication, fatigue, group size, session attendance and tutor availability. Collection of the primary outcome by telephone gave high return rates.</p>
                <p>There was no control for social effects of RAFT groups: seven sessions of didactic information would not reflect usual care and likely incur high attrition. In the original RCT, patients reported benefit from interactions with other patients, but considered tutors more important, otherwise patients would have ‘pulled one another down’.<xref rid="R44" ref-type="bibr">44</xref> Delay between screening and baseline assessment was inevitable while building cohorts for randomisation, and some patients no longer had eligible fatigue severity scores at baseline. However, RAFT still had an overall treatment effect, with a greater effect in baseline-eligible participants. Delays would be shorter in clinical practice as only sufficient patients for a RAFT group need be recruited. Six RAFT patients requested a later course and had a fresh baseline assessment, collected after randomisation. Major medication changes might influence fatigue but changes were not different between arms and remission through optimal medication does not resolve problematic fatigue.<xref rid="R45" ref-type="bibr">45</xref> We did not collect follow-up data on 25 patients who withdrew, but imputing missing data did not change the primary outcome analysis. RAFT patients were not asked to rate the usual care booklet.</p>
              </sec>
              <sec id="s4-2">
                <title>Implications for research</title>
                <p>Codelivery by a rheumatology professional and a patient (bringing experiential knowledge of RA fatigue) could be evaluated,<xref rid="R46" ref-type="bibr">46</xref> as could delivery in physical long-term conditions with fatigue (multiple sclerosis, Parkinson’s disease) and the MCID for the BRAF-NRS Effect established.</p>
              </sec>
              <sec id="s4-3">
                <title>Implications for healthcare</title>
                <p>The CBA intervention was delivered by clinical rheumatology nurses and occupational therapists, addressing the lack of rheumatology psychologists.<xref rid="R12" ref-type="bibr">12</xref> Similar success has been demonstrated in multiple sclerosis fatigue.<xref rid="R47" ref-type="bibr">47</xref> RAFT delivery by clinical teams was feasible: all planned RAFT courses were delivered, tutor absence was managed and patient attendance high. Increasing group size to 8–10 patients would be feasible, as would including patients with other inflammatory rheumatic diseases and fatigue.<xref rid="R48" ref-type="bibr">48 49</xref> Several RCT centres now deliver RAFT clinically.</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <p>We would like to thank the 14 RAFT tutors, the research nurses in the 7 participating hospitals and the patients for their participation. This study was designed and delivered in collaboration with the Bristol Randomised Trials Collaboration (BRTC), a UKCRC Registered Clinical Trials Unit which, as part of the Bristol Trials Centre, is in receipt of National Institute for Health Research CTU support funding.</p>
            </ack>
            <fn-group>
              <fn fn-type="other">
                <p><bold>Handling editor:</bold> Josef S Smolen</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Presented at:</bold> Some of these findings have been presented as published abstracts at international.<xref rid="R32" ref-type="bibr">32 33</xref></p>
              </fn>
              <fn fn-type="other">
                <p><bold>Collaborators:</bold> The RAFT study group: In addition to the listed authors, this comprises P Creamer and R Hughes (local PIs throughout), B Knops and R Cheston (intervention training and monitoring). The authors would like thank the following for their collaboration: S Green, S Webber, P Thompson, N Viner, K Mackay (local PIs); F Robinson (patient research partner) and D Carmichael (database and randomisation services, Bristol Randomised Trial Collaboration).</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Contributors:</bold> SH is the chief investigator responsible for the trial, led the study team, supervised the conduct of the trial, analysis and reporting and drafted the manuscript. SH, NA and JP jointly conceived the original idea and led on the trial design and protocol. PSB, WH, EHC, JRK and ED contributed to trial design. NA, SH, ED, BK and AH developed the RAFT intervention materials and delivered the tutor training and RC monitored programme delivery (quality assurance). PSB, WH, JT, BK, NT and JP led on the statistical design and analysis, including health economics. ZP, CA and CR, along with all other authors, contributed to methods of data collection, patient materials and data management. ZP managed the trial with CA, including research governance, data collection, data entry and validation. DC was responsible for randomisation. JRK, PC, EHC, NV, KM, SG, SW, PT and RH led recruitment at the 7 centres. All authors reviewed, discussed and helped interpret the findings, commented on and approved the final version of the manuscript.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Funding:</bold> This research was funded by a National Institutes for Health Research Health Technology Award: 11/112/01.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Disclaimer:</bold> The views expressed in this paper are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Competing interests:</bold> None declared.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Patient consent for publication:</bold> Not required.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Data sharing statement:</bold> Results from the health economics and qualitative evaluations will be published as two further papers.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walter</surname><given-names>MJM</given-names></name>, <name name-style="western"><surname>Kuijper</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Hazes</surname><given-names>JMW</given-names></name>, <etal>et al</etal></person-group><article-title>Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study</article-title>. <source>Rheumatol Int</source><year>2018</year>;<volume>38</volume>:<fpage>1643</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-018-4102-5</pub-id><pub-id pub-id-type="pmid">30014260</pub-id></mixed-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cockshott</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Byron</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group><article-title>Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored</article-title>. <source>Arthritis Rheum</source><year>2005</year>;<volume>53</volume>:<fpage>697</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1002/art.21450</pub-id><pub-id pub-id-type="pmid">16208668</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Repping Wuts</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Uitterhoeve</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Riel</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group><article-title>Fatigue as experienced by patients with rheumatoid arthritis</article-title>. <source>Int J Nurs Stud</source><year>2008</year>;<volume>45</volume>:<fpage>995</fpage>–<lpage>1002</lpage>.<pub-id pub-id-type="pmid">17662291</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Druce</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Macfarlane</surname><given-names>GJ</given-names></name>, <etal>et al</etal></person-group><article-title>The longitudinal course of fatigue in rheumatoid arthritis: results from the norfolk arthritis register</article-title>. <source>J Rheumatol</source><year>2015</year>;<volume>42</volume>:<fpage>2059</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.141498</pub-id><pub-id pub-id-type="pmid">26472420</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Repping-Wuts</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>van Riel</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group><article-title>Fatigue in patients with rheumatoid arthritis: British and Dutch nurses’ knowledge, attitudes and management</article-title>. <source>J Adv Nursing</source><year>2009</year>;<volume>65</volume>:<fpage>901</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2648.2008.04904.x</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikolaus</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bode</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Taal</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group><article-title>Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review</article-title>. <source>Arthritis Care Res</source><year>2013</year>;<volume>65</volume>:<fpage>1128</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1002/acr.21949</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chalder</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Choy</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group><article-title>Fatigue in rheumatoid arthritis: time for a conceptual model</article-title>. <source>Rheumatology</source><year>2011</year>;<volume>50</volume>:<fpage>1004</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keq282</pub-id><pub-id pub-id-type="pmid">20819797</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Choy</surname><given-names>EHS</given-names></name>, <name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name></person-group>, <year>2016</year><article-title>Biologic interventions for fatigue in rheumatoid arthritis (systematic review). Cochrane systematic reviews</article-title>. Available: <uri xlink:href="https://www.cochranelibrary.com/cdsr/">https://www.cochranelibrary.com/cdsr/</uri> [Accessed <comment>5 Sep 2018</comment>].</mixed-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cramp</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group><article-title>Non-pharmacological interventions for fatigue in rheumatoid arthritis</article-title>. <source>Cochrane Database of Systematic Reviews</source><year>2013</year>;<volume>44</volume>:<elocation-id>CD008322</elocation-id><pub-id pub-id-type="doi">10.1002/14651858.CD008322.pub2</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evers</surname><given-names>AWM</given-names></name>, <name name-style="western"><surname>Kraaimaat</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>van Riel</surname><given-names>PLCM</given-names></name>, <etal>et al</etal></person-group><article-title>Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial</article-title>. <source>Pain</source><year>2002</year>;<volume>100</volume>:<fpage>141</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3959(02)00274-9</pub-id><pub-id pub-id-type="pmid">12435467</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ambler</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group><article-title>Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy</article-title>. <source>Ann Rheum Dis</source><year>2011</year>;<volume>70</volume>:<fpage>1060</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2010.144691</pub-id><pub-id pub-id-type="pmid">21540202</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dures</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Caesley</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group><article-title>A survey of psychological support provision for people with inflammatory arthritis in secondary care in England</article-title>. <source>Musculoskelet Care</source><year>2014</year>;<volume>12</volume>:<fpage>173</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/msc.1071</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ambler</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group><article-title>Protocol for a randomised controlled trial for reducing arthritis fatigue by clinical teams (raft) using cognitive-behavioural approaches</article-title>. <source>BMJ Open</source><year>2015</year>;<volume>5</volume>:<elocation-id>e009061</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2015-009061</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnett</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Edworthy</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Bloch</surname><given-names>DA</given-names></name>, <etal>et al</etal></person-group><article-title>The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis</article-title>. <source>Arthritis Rheum</source><year>1988</year>;<volume>31</volume>:<fpage>315</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/art.1780310302</pub-id><pub-id pub-id-type="pmid">3358796</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicklin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cramp</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kirwan</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group><article-title>Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol rheumatoid arthritis fatigue multi-dimensional questionnaire, visual analog scales, and numerical rating scales</article-title>. <source>Arthritis Care Res</source><year>2010</year>;<volume>62</volume>:<fpage>1559</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1002/acr.20282</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Sage</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sowden</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chorlton</surname><given-names>E</given-names></name></person-group><chapter-title>Guided discovery: using the Socratic method</chapter-title> : <person-group person-group-type="editor"><name name-style="western"><surname>Sage</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sowden</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chorlton</surname><given-names>E</given-names></name></person-group>, <source>Cognitive Behaviour Therapy for Chronic Illness and Palliative Care</source>. <publisher-loc>Chichester</publisher-loc>: <publisher-name>Wiley</publisher-name>, <year>2008</year>: <fpage>66</fpage>–<lpage>77</lpage>.</mixed-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bandura</surname><given-names>A</given-names></name></person-group><article-title>Self-efficacy: toward a unifying theory of behavioral change</article-title>. <source>Psychol Rev</source><year>1977</year>;<volume>84</volume>:<fpage>191</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1037/0033-295X.84.2.191</pub-id><pub-id pub-id-type="pmid">847061</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ambler</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dures</surname><given-names>E</given-names></name></person-group>, <year>2011</year><article-title>Arthritis Research UK. self-help and daily living: fatigue and arthritis</article-title>. Available: <uri xlink:href="www.arthritisresearchuk.org/~/media/Files/Arthritis-information/Living-with-arthritis/2269-Fatigue-and-Arthritis-inc-excercise-book.ashx">www.arthritisresearchuk.org/~/media/Files/Arthritis-information/Living-with-arthritis/2269-Fatigue-and-Arthritis-inc-excercise-book.ashx</uri> [Accessed <comment>11 May 2018</comment>].</mixed-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pincus</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Summey</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Soraci</surname><given-names>SA</given-names></name>, <etal>et al</etal></person-group><article-title>Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment Questionnaire</article-title>. <source>Arthritis Rheum</source><year>1983</year>;<volume>26</volume>:<fpage>1346</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1002/art.1780261107</pub-id><pub-id pub-id-type="pmid">6639693</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buysse</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Monk</surname><given-names>TH</given-names></name>, <etal>et al</etal></person-group><article-title>The Pittsburgh sleep quality index</article-title>. <source>Psychiatry Res</source><year>1989</year>;<volume>28</volume>:<fpage>193</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="pmid">2748771</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Heijde</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>van ‘t Hof</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Riel</surname><given-names>PL</given-names></name>, <etal>et al</etal></person-group><article-title>Development of a disease activity score based on judgement in clinical practice by rheumatologists</article-title>. <source>J Rheumatol</source><year>1993</year>;<volume>20</volume>:<fpage>579</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">8478878</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choy</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Khoshaba</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group><article-title>Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice</article-title>. <source>Arthritis Rheum</source><year>2008</year>;<volume>59</volume>:<fpage>192</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/art.23342</pub-id><pub-id pub-id-type="pmid">18240256</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choy</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>AMH</given-names></name></person-group><article-title>THU0083 Simplified Patient-Derived Disease Activity Score (SPDAS2): A Simplified Version without Early Morning Stiffness</article-title>. <source>Ann Rheum Dis</source><year>2016</year>;<volume>75</volume>(<issue>Suppl 2</issue>):<fpage>209.1</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2016-eular.1443</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zigmond</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Snaith</surname><given-names>RP</given-names></name></person-group><article-title>The hospital anxiety and depression scale</article-title>. <source>Acta Psychiatr Scand</source><year>1983</year>;<volume>67</volume>:<fpage>361</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.1983.tb09716.x</pub-id><pub-id pub-id-type="pmid">6880820</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meenan</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Gertman</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>JH</given-names></name></person-group><article-title>Measuring health status in arthritis: the arthritis impact measurement scales</article-title>. <source>Arthritis Rheum</source><year>1980</year>;<volume>23:2</volume>:<fpage>146</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">7362665</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yelin</surname><given-names>EH</given-names></name></person-group><article-title>Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis</article-title>. <source>Ann Rheum Dis</source><year>2006</year>;<volume>65</volume>:<fpage>763</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2005.044677</pub-id><pub-id pub-id-type="pmid">16249225</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE)</article-title>. <source>Rheumatology</source><year>2001</year>;<volume>40</volume>:<fpage>1221</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/40.11.1221</pub-id><pub-id pub-id-type="pmid">11709605</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stein</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Wallston</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Nicassio</surname><given-names>PM</given-names></name></person-group><article-title>Factor structure of arthritis helplessness index</article-title>. <source>J Rheumatol</source><year>1988</year>;<volume>15</volume>:<fpage>427</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">3379620</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamb</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Hansen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Lall</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group><article-title>Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis</article-title>. <source>Lancet</source><year>2010</year>;<volume>375</volume>:<fpage>916</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(09)62164-4</pub-id><pub-id pub-id-type="pmid">20189241</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <label>30</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><collab>CONSORT</collab></person-group>, <year>2018</year><article-title>(consolidating standards of reporting trials) statement, checklist and flowchart</article-title>. Available: <uri xlink:href="www.consort-statement.org">www.consort-statement.org</uri> [Accessed <comment>10 Apr 2018</comment>].</mixed-citation>
              </ref>
              <ref id="R31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Connell</surname><given-names>AM</given-names></name></person-group><article-title>Employing complier average causal effect analytic methods to examine effects of randomized encouragement trials</article-title>. <source>Am J Drug Alcohol Abuse</source><year>2009</year>;<volume>35</volume>:<fpage>253</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1080/00952990903005882</pub-id><pub-id pub-id-type="pmid">20180678</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ambler</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name></person-group><article-title>Reducing arthritis fatigue – clinical teams (raft) using cognitive behavioural approaches: an RCT</article-title>. <source>Ann Rheum Dis</source><year>2017</year>;<volume>76110</volume>.</mixed-citation>
              </ref>
              <ref id="R33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ambler</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name></person-group><article-title>Reducing arthritis fatigue – clinical teams (raft) using cognitive behavioural approaches: an RCT</article-title>. <source>Rheumatology</source><year>2018</year>;<volume>57</volume>:<fpage>key075.180</fpage>.</mixed-citation>
              </ref>
              <ref id="R34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hart</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>W-F</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>JL</given-names></name>, <etal>et al</etal></person-group><article-title>What impact does written information about fatigue have on patients with autoimmune rheumatic diseases? Findings from a qualitative study</article-title>. <source>Musculoskelet Care</source><year>2017</year>;<volume>15</volume>:<fpage>230</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/msc.1164</pub-id></mixed-citation>
              </ref>
              <ref id="R35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khanna</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pope</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Khanna</surname><given-names>PP</given-names></name>, <etal>et al</etal></person-group><article-title>The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice</article-title>. <source>J Rheumatol</source><year>2008</year>;<volume>35</volume>:<fpage>2339</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.080375</pub-id><pub-id pub-id-type="pmid">19004044</pub-id></mixed-citation>
              </ref>
              <ref id="R36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wells</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Maxwell</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group><article-title>Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis</article-title>. <source>J Rheumatol</source><year>2007</year>;<volume>34</volume>:<fpage>280</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17304654</pub-id></mixed-citation>
              </ref>
              <ref id="R37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kherani RB</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Brant</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lacaille</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group><article-title>Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis</article-title>. <source>J Clin Epidemiol</source><year>2008</year>;<volume>61</volume>:<fpage>705</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">18359189</pub-id></mixed-citation>
              </ref>
              <ref id="R38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Learmonth</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Dlugonski</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pilutti</surname><given-names>LA</given-names></name>, <etal>et al</etal></person-group><article-title>Psychometric properties of the fatigue Severity Scale and the modified fatigue Impact Scale</article-title>. <source>J Neurol Sci</source><year>2013</year>;<volume>331</volume>:<fpage>102</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2013.05.023</pub-id><pub-id pub-id-type="pmid">23791482</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kos</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Duportail</surname><given-names>M</given-names></name>, <name name-style="western"><surname>D'hooghe</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group><article-title>Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial</article-title>. <source>Mult Scler</source><year>2007</year>;<volume>13</volume>:<fpage>996</fpage>–<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1177/1352458507078392</pub-id><pub-id pub-id-type="pmid">17623738</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Steenbergen</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Tsonaka</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Huizinga</surname><given-names>TWJ</given-names></name>, <etal>et al</etal></person-group><article-title>Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study</article-title>. <source>RMD Open</source><year>2015</year>;<volume>1</volume>:<elocation-id>e00041</elocation-id>:<fpage>e000041</fpage><pub-id pub-id-type="doi">10.1136/rmdopen-2014-000041</pub-id></mixed-citation>
              </ref>
              <ref id="R41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hewlett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Kirwan</surname><given-names>JR</given-names></name></person-group><article-title>Measuring the meaning of disability in rheumatoid arthritis: the personal impact health assessment Questionnaire (PI HAQ)</article-title>. <source>Ann Rheum Dis</source><year>2002</year>;<volume>61</volume>:<fpage>986</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1136/ard.61.11.986</pub-id><pub-id pub-id-type="pmid">12379521</pub-id></mixed-citation>
              </ref>
              <ref id="R42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seror</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tubach</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Baron</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group><article-title>Measure of function in rheumatoid arthritis: individualised or classical scales?</article-title><source>Ann Rheum Dis</source><year>2010</year>;<volume>69</volume>:<fpage>97</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2008.102137</pub-id><pub-id pub-id-type="pmid">19346220</pub-id></mixed-citation>
              </ref>
              <ref id="R43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanderson</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Hewlett</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Flurey</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group><article-title>The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases</article-title>. <source>J Rheumatol</source><year>2011</year>;<volume>38</volume>:<fpage>191</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.100700</pub-id><pub-id pub-id-type="pmid">21285178</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dures</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kitchen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group><article-title>“They didn't tell us, they made us work it out ourselves”: Patient perspectives of a cognitive-behavioral program for rheumatoid arthritis fatigue</article-title>. <source>Arthritis Care Res</source><year>2012</year>;<volume>64</volume>:<fpage>494</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1002/acr.21562</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Druce</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Bhattacharya</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>GT</given-names></name>, <etal>et al</etal></person-group><article-title>Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the british Society for rheumatology biologics register for rheumatoid arthritis</article-title>. <source>Rheumatology</source><year>2016</year>;<volume>55</volume>:<fpage>1786</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/kew241</pub-id><pub-id pub-id-type="pmid">27330158</pub-id></mixed-citation>
              </ref>
              <ref id="R46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Wallace</surname><given-names>LM</given-names></name>, <etal>et al</etal></person-group><article-title>An evaluation of a self-management program for patients with long-term conditions</article-title>. <source>Patient Educ Counsel</source><year>2015</year>;<volume>98</volume>:<fpage>213</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.pec.2014.08.022</pub-id></mixed-citation>
              </ref>
              <ref id="R47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Kersten</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group><article-title>A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (facets) for people with multiple sclerosis</article-title>. <source>J Neurol Neurosurg Psychiatry</source><year>2013</year>;<volume>84</volume>:<fpage>1092</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-303816</pub-id><pub-id pub-id-type="pmid">23695501</pub-id></mixed-citation>
              </ref>
              <ref id="R48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tench</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>McCurdie</surname><given-names>I</given-names></name>, <name name-style="western"><surname>White</surname><given-names>PD</given-names></name>, <etal>et al</etal></person-group><article-title>The prevalence and associations of fatigue in systemic lupus erythematosus</article-title>. <source>Rheumatology</source><year>2000</year>;<volume>39</volume>:<fpage>1249</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/39.11.1249</pub-id><pub-id pub-id-type="pmid">11085805</pub-id></mixed-citation>
              </ref>
              <ref id="R49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gudu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Etcheto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group><article-title>Fatigue in psoriatic arthritis – a cross-sectional study of 246 patients from 13 countries</article-title>. <source>Joint Bone Spine</source><year>2016</year>;<volume>83</volume>:<fpage>439</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbspin.2015.07.017</pub-id><pub-id pub-id-type="pmid">27055727</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
